Population
HeLa cells infected with two strains of coxsackievirus B3
Design
Preclinical
Authors
Loading...
Co-targeting DAF and CAR merits exploration as CVB3 therapy; leaves open clinical translation from animal data.
Both haemagglutinating and non-haemagglutinating strains of coxsackievirus B3 preferentially interact with closely associated DAF and CAR proteins on host cells.
Pasch et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: